Insider Transactions in Q1 2025 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
Stephen F. Betz Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,000
+27.33%
|
-
|
|
Feb 20
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,000
+36.52%
|
-
|
|
Feb 20
2025
|
Jeff E. Knight Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,000
+31.24%
|
-
|
|
Feb 20
2025
|
Richard Scott Struthers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
89,000
+20.44%
|
-
|
|
Feb 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
5,000
-13.61%
|
$195,000
$39.07 P/Share
|
|
Feb 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.98%
|
$80,000
$16.89 P/Share
|
|
Jan 07
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.3%
|
$47,500
$19.64 P/Share
|
|
Jan 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
15,000
-33.9%
|
$780,000
$52.09 P/Share
|
|
Jan 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.32%
|
$240,000
$16.89 P/Share
|